Health-Related Quality of Life in Patients with Friedreich Ataxia Using Mobility Assistive Technologies: Limited Fit of the EQ-5D-3L Mobility Dimension
Abstract Introduction Friedreich Ataxia (FA) is a multisystem neurodegenerative disease. Affected individuals rely on mobility assistive technologies (MAT) (e.g. wheelchairs) and require long-term treatments and care. To analyse the patients’ health-related quality of life (HRQoL), the EuroQol 5 Dim...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2024-12-01
|
| Series: | Neurology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40120-024-00694-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832585272020172800 |
|---|---|
| author | Maresa Buchholz Michelle Pfaff Audrey Iskandar Kathrin Reetz Jörg B. Schulz Marcus Grobe-Einsler Thomas Klockgether Bernhard Michalowsky EFACTS Study Group |
| author_facet | Maresa Buchholz Michelle Pfaff Audrey Iskandar Kathrin Reetz Jörg B. Schulz Marcus Grobe-Einsler Thomas Klockgether Bernhard Michalowsky EFACTS Study Group |
| author_sort | Maresa Buchholz |
| collection | DOAJ |
| description | Abstract Introduction Friedreich Ataxia (FA) is a multisystem neurodegenerative disease. Affected individuals rely on mobility assistive technologies (MAT) (e.g. wheelchairs) and require long-term treatments and care. To analyse the patients’ health-related quality of life (HRQoL), the EuroQol 5 Dimension 3 Level survey (EQ-5D-3L)—a widely used and recommended generic measure—is used in clinical and in health economic studies. Concerns about using the instrument in mobility-impaired individuals who might have difficulties finding appropriate response options for mobility-related items led us to investigate how the 3L dimensions perform in patients with FA using or not using MAT. Methods Using longitudinal data from 607 patients with FA of the EFACTS study (from baseline to the 3-year follow-up), we analysed the acceptability, distribution properties, validity, and responsiveness of the EQ-5D-3L, focusing on the mobility item. Analyses were stratified for patients without and with different MAT-usage. Results We identified that n = 177 patients used no MAT, n = 299 a wheelchair and n = 131 walking aids. The mobility item non-response was highest in wheelchair users (6.8%) and lowest in patients without MAT. Walking aid users showed the least variability, all selecting the mid-response option “some problems” for mobility. The mobility item correlated moderately with disease severity (r sp = 0.35) and the activities of daily living scale (r sp = 0.36) in wheelchair users. No correlation exists for walking aid users. The strongest health changes occurred for wheelchair users, the weakest for walking aid users. The mobility dimensions showed the highest amount of no changes. Conclusion The EQ-5D-3L’s mobility item has limitations in MAT users, particularly in walking aid users, due to a tendency towards mid-responses. These limitations may affect the efficacy and (cost)effectiveness conclusions drawn from interventions and clinical trials with mobility-impaired individuals. Further research is needed to explore the understanding and interpretation of responses of the EQ-5D in patients with FA with mobility support. Trial Registration ClinicalTrials.gov identifier NCT02069509. |
| format | Article |
| id | doaj-art-3a36accb04fc4134aa4e267917e0045b |
| institution | Kabale University |
| issn | 2193-8253 2193-6536 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Adis, Springer Healthcare |
| record_format | Article |
| series | Neurology and Therapy |
| spelling | doaj-art-3a36accb04fc4134aa4e267917e0045b2025-01-26T12:58:33ZengAdis, Springer HealthcareNeurology and Therapy2193-82532193-65362024-12-0114137939810.1007/s40120-024-00694-7Health-Related Quality of Life in Patients with Friedreich Ataxia Using Mobility Assistive Technologies: Limited Fit of the EQ-5D-3L Mobility DimensionMaresa Buchholz0Michelle Pfaff1Audrey Iskandar2Kathrin Reetz3Jörg B. Schulz4Marcus Grobe-Einsler5Thomas Klockgether6Bernhard Michalowsky7EFACTS Study GroupPatient-Reported Outcomes and Health Economics Research, Deutsches Zentrum für Neurodegenerative Erkrankungen/German Center for Neurodegenerative Diseases (DZNE), Site Rostock/GreifswaldPatient-Reported Outcomes and Health Economics Research, Deutsches Zentrum für Neurodegenerative Erkrankungen/German Center for Neurodegenerative Diseases (DZNE), Site Rostock/GreifswaldPatient-Reported Outcomes and Health Economics Research, Deutsches Zentrum für Neurodegenerative Erkrankungen/German Center for Neurodegenerative Diseases (DZNE), Site Rostock/GreifswaldDepartment of Neurology, RWTH Aachen UniversityDepartment of Neurology, RWTH Aachen UniversityDeutsches Zentrum für Neurodegenerative Erkrankungen/German Center for Neurodegenerative Diseases (DZNE), Site BonnDeutsches Zentrum für Neurodegenerative Erkrankungen/German Center for Neurodegenerative Diseases (DZNE), Site BonnPatient-Reported Outcomes and Health Economics Research, Deutsches Zentrum für Neurodegenerative Erkrankungen/German Center for Neurodegenerative Diseases (DZNE), Site Rostock/GreifswaldAbstract Introduction Friedreich Ataxia (FA) is a multisystem neurodegenerative disease. Affected individuals rely on mobility assistive technologies (MAT) (e.g. wheelchairs) and require long-term treatments and care. To analyse the patients’ health-related quality of life (HRQoL), the EuroQol 5 Dimension 3 Level survey (EQ-5D-3L)—a widely used and recommended generic measure—is used in clinical and in health economic studies. Concerns about using the instrument in mobility-impaired individuals who might have difficulties finding appropriate response options for mobility-related items led us to investigate how the 3L dimensions perform in patients with FA using or not using MAT. Methods Using longitudinal data from 607 patients with FA of the EFACTS study (from baseline to the 3-year follow-up), we analysed the acceptability, distribution properties, validity, and responsiveness of the EQ-5D-3L, focusing on the mobility item. Analyses were stratified for patients without and with different MAT-usage. Results We identified that n = 177 patients used no MAT, n = 299 a wheelchair and n = 131 walking aids. The mobility item non-response was highest in wheelchair users (6.8%) and lowest in patients without MAT. Walking aid users showed the least variability, all selecting the mid-response option “some problems” for mobility. The mobility item correlated moderately with disease severity (r sp = 0.35) and the activities of daily living scale (r sp = 0.36) in wheelchair users. No correlation exists for walking aid users. The strongest health changes occurred for wheelchair users, the weakest for walking aid users. The mobility dimensions showed the highest amount of no changes. Conclusion The EQ-5D-3L’s mobility item has limitations in MAT users, particularly in walking aid users, due to a tendency towards mid-responses. These limitations may affect the efficacy and (cost)effectiveness conclusions drawn from interventions and clinical trials with mobility-impaired individuals. Further research is needed to explore the understanding and interpretation of responses of the EQ-5D in patients with FA with mobility support. Trial Registration ClinicalTrials.gov identifier NCT02069509.https://doi.org/10.1007/s40120-024-00694-7Friedreich AtaxiaHealth-related quality of lifeMobility assistive technologyEQ-5D-3L |
| spellingShingle | Maresa Buchholz Michelle Pfaff Audrey Iskandar Kathrin Reetz Jörg B. Schulz Marcus Grobe-Einsler Thomas Klockgether Bernhard Michalowsky EFACTS Study Group Health-Related Quality of Life in Patients with Friedreich Ataxia Using Mobility Assistive Technologies: Limited Fit of the EQ-5D-3L Mobility Dimension Neurology and Therapy Friedreich Ataxia Health-related quality of life Mobility assistive technology EQ-5D-3L |
| title | Health-Related Quality of Life in Patients with Friedreich Ataxia Using Mobility Assistive Technologies: Limited Fit of the EQ-5D-3L Mobility Dimension |
| title_full | Health-Related Quality of Life in Patients with Friedreich Ataxia Using Mobility Assistive Technologies: Limited Fit of the EQ-5D-3L Mobility Dimension |
| title_fullStr | Health-Related Quality of Life in Patients with Friedreich Ataxia Using Mobility Assistive Technologies: Limited Fit of the EQ-5D-3L Mobility Dimension |
| title_full_unstemmed | Health-Related Quality of Life in Patients with Friedreich Ataxia Using Mobility Assistive Technologies: Limited Fit of the EQ-5D-3L Mobility Dimension |
| title_short | Health-Related Quality of Life in Patients with Friedreich Ataxia Using Mobility Assistive Technologies: Limited Fit of the EQ-5D-3L Mobility Dimension |
| title_sort | health related quality of life in patients with friedreich ataxia using mobility assistive technologies limited fit of the eq 5d 3l mobility dimension |
| topic | Friedreich Ataxia Health-related quality of life Mobility assistive technology EQ-5D-3L |
| url | https://doi.org/10.1007/s40120-024-00694-7 |
| work_keys_str_mv | AT maresabuchholz healthrelatedqualityoflifeinpatientswithfriedreichataxiausingmobilityassistivetechnologieslimitedfitoftheeq5d3lmobilitydimension AT michellepfaff healthrelatedqualityoflifeinpatientswithfriedreichataxiausingmobilityassistivetechnologieslimitedfitoftheeq5d3lmobilitydimension AT audreyiskandar healthrelatedqualityoflifeinpatientswithfriedreichataxiausingmobilityassistivetechnologieslimitedfitoftheeq5d3lmobilitydimension AT kathrinreetz healthrelatedqualityoflifeinpatientswithfriedreichataxiausingmobilityassistivetechnologieslimitedfitoftheeq5d3lmobilitydimension AT jorgbschulz healthrelatedqualityoflifeinpatientswithfriedreichataxiausingmobilityassistivetechnologieslimitedfitoftheeq5d3lmobilitydimension AT marcusgrobeeinsler healthrelatedqualityoflifeinpatientswithfriedreichataxiausingmobilityassistivetechnologieslimitedfitoftheeq5d3lmobilitydimension AT thomasklockgether healthrelatedqualityoflifeinpatientswithfriedreichataxiausingmobilityassistivetechnologieslimitedfitoftheeq5d3lmobilitydimension AT bernhardmichalowsky healthrelatedqualityoflifeinpatientswithfriedreichataxiausingmobilityassistivetechnologieslimitedfitoftheeq5d3lmobilitydimension AT efactsstudygroup healthrelatedqualityoflifeinpatientswithfriedreichataxiausingmobilityassistivetechnologieslimitedfitoftheeq5d3lmobilitydimension |